Medication effect

What is most likely responsible for this urinary discoloration seen in a critically ill patient in the ICU?

  1. Beet consumption
  2. Medication effect
  3. Porphyria
  4. Rhabdomyolysis

[Authors own image]

2. Medication effect

Background

Medications often cause benign changes in urine color, such as rifampin’s well-known orange-hued body fluids. In this case, the patient suffered calcium channel blocker toxicity and was administered both hydroxocobalamin and methylene blue to treat refractory hypotension. Hydroxocobalamin, typically used to manage cyanide toxicity, causes red discoloration in urine while methylene blue, classically used to manage methemoglobinemia, causes blue-green urine [1-3].  The combination of both can result in purple urine as above [3].

What else causes purple or purple-like urine?

  • Purple Urine Bag Syndrome is a condition associated with chronic catheter use and constipation thought to be caused by a byproduct of bacterial metabolism interacting with the catheter bag and/or tubing [4,5].
  • Beets contain a red pigment called betacyanin, which discolors urine anywhere from pink to deep red [6].
  • Porphyria can produce a red-to-brown spectrum of urinary discoloration due to the content of porphyrin intermediates [7].

Bedside Pearls: A rainbow differential of urine colors [7]

  • Reds: Hematuria/hemoglobinuria, myoglobinuria, some UTIs (e.g., serratia), beeturia, hydroxocobalamin
  • Oranges: rifampin, uric acid (urate crystals produce an orange-spectrum precipitate, such as in Lesch-Nyhan Syndrome)
  • Yellows: urobilinogen/bilirubin content, vitamin B
  • Greens: phenol-containing compounds (e.g., propofol), indole production (Hartnup disease, blue diaper syndrome), pyocyanin/pyoverdin production from Pseudomonas
  • Blues: methylene blue, Familial indicanuria (Familial Benign Hypercalcemia)
  • Brown/black: severe hemolysis/rhabdomyolysis, paraphenylene diamine poisoning (hair dye), malignant melanoma

References

  1. Wong SL, Pudek M, Li D. Wine-Colored Plasma and Urine from Hydroxocobalamin Treatment. J Gen Intern Med. 2017;32(2):225-226. PMID: 27338592.
  2. Aklilu AM, Avigan ZM, Brewster UC. A unique case of purple urine: A case report and literature review. Clin Nephrol. 2021;95(5):273-277.  PMID: 33605870.
  3. Hardin J, Galust H, Clark RF, Ly B, Suhandynata RT. Spectrophotometric analysis of purple urine secondary to methylene blue and hydroxocobalamin co-administration. J Nephrol. 2024;37(2):491-494. PMID: 37644365.
  4. Al Montasir A, Al Mustaque A. Purple urine bag syndrome. J Family Med Prim Care. 2013;2(1):104-105. PMID: 24479059.
  5. Reid S, Brocksom J, Hamid R, et al. British Association of Urological Surgeons (BAUS) and Nurses (BAUN) consensus document: management of the complications of long-term indwelling catheters. BJU Int. 2021;128(6):667-677. PMID: 33811741.
  6. Sauder HM, Rawla P. Beeturia. StatPearls: StatPearls 05/22/2023. Accessed 05/17/24.
  7. Viswanathan S. Urine bag as a modern day matula. ISRN Nephrol. 2013;2013:215690. Published 2013 May 23. PMID: 24959539
Kellie LeVine McKenzie, MD

Kellie LeVine McKenzie, MD

Emergency Medicine Resident
Emory University, Atlanta, GA
Kellie LeVine McKenzie, MD

Latest posts by Kellie LeVine McKenzie, MD (see all)

Matthew Robert Dernbach, MD

Matthew Robert Dernbach, MD

Medical Toxicology Fellow
Emory University, Atlanta, GA
Matthew Robert Dernbach, MD

Latest posts by Matthew Robert Dernbach, MD (see all)